AGPU · CIK 0001446159 · FY2025 live · 2025-12-31
Axe Compute Inc.
View as
Model
Classic Z
FY2025
−15.82
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−15.82
Z″ −34.01
Score −15.82 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.731.2 × = 0.87X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.821.4 × = −10.95X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−3.423.3 × = −11.29X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
9.230.6 × = 5.54X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Meridian Rank
3.64
0–100 · Classic Z tape · not a PD
Book standing
5
Year change
—
Market PD
—
O-score
0
Events on this name
Same published rows as Today. Not a live recompute.
Market PD unavailable
watch · 41
Overview
rule-v1
Axe Compute Inc. is on classic Z at −15.82 (distress) for FY2025, from an SEC 10-K. EBIT / assets is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 9th percentile in Healthcare.
- SCNIDistressScinai Immunotherapeutics Ltd.−15.75
- STXSDistressStereotaxis, Inc.−15.90
- LTRNDistressLantern Pharma Inc.−15.64
- APVODistressAptevo Therapeutics Inc.−15.54
- CELUDistressCelularity Inc−15.49
- VTGNDistressVistagen Therapeutics, Inc.−16.18
- VERUDistressVERU INC.−16.22
- MBRXDistressMoleculin Biotech, Inc.−15.36
KPI widgets
Current assets
$43M
Total assets
$53M
Current liabilities
$4M
Total liabilities
$5M
Working capital
$39M
Retained earnings
−$414M
EBIT
−$181M
Total sales
$0
Book equity
$48M
Accession 0001171843-26-002094. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.